Intellectual Property Issues in Biotechnology

October 2016
More details
  • Publisher
  • Published
    31st October 2016
  • ISBN 9781780646534
  • Language English
  • Pages 276 pp.
  • Size 7.5" x 9.625"
  • Images figures & tables

Adopting a unique approach, and with case studies and examples from developing economy markets, this book integrates science and business to provide an introduction and an insider view of intellectual property issues within the biotech industry. Broad in scope, the book covers key principles in pharmaceutical, industrial and agricultural biotechnology within four sections.

The first section details the principles of intellectual property and biotechnology, the second section covers plant biotechnology, including biotic and abiotic stress tolerance, GM foods in sustainable agriculture, microbial biodiversity and bioprospecting for improving crop health and productivity, and production and regulatory requirements of biopesticides and biofertilizers. The third section describes recent advances in industrial biotechnology, such as DNA patenting, and commercial viability of the CRISPR/Cas9 system in genome editing. The final section describes intellectual property issues in drug discovery and development, personalized medicine, and vaccines in biodefense.

Section 1: Biotechnology and Intellectual Property Issues
1. Biotechnology in Agriculture, Medicine and Industry: An Overview—Harikesh Bahadur Singh
2. Biotechnology and its Development in Developing Countries: Can IPR’s Foster Innovation in the Field? —Dhanay M Cadillo Chandler
3. Patent Eligibility Issues in Life Science Innovations: Contentious Court Cases—Ananda M. Chakrabarty
4. Checks and Balances in Biotechnology Related Patents: In Agreement to the Indian Patents (Amendment) Act, 2005—Om Prakash & Poonam C. Singh
5. Intellectual Property in Biotechnology Sector. The Importance of “Star Scientists” in the Entrepreneurship and Universities Environment—Tomas Gabriel Bas

Section 2: Intellectual Property Issues in Agricultural Biotechnology
6. Intellectual Property in Agricultural Biotechnology: From Patent Thickets to Generics—Alan B Bennett, David J Jefferson & Monica Alandete-Saez
7. Bioprospecting for Improving Soil Health and Crop Productivity: Indian Patent Landscape—Aradhana Mishra, Chandra S Nautiyal, Swati Sharma, Vivek Srivastava & Puneet S Chauhan
8. Seeds of Change: Genetically Modified Crops, Canada’s Agricultural Growth Act and the Erosion of Farmers’ Privilege—Elisabeth Abergel
9. Recent Innovations in Agricultural Biotechnology: Challenging the Status Quo—Kathleen L. Hefferon
10. Chinese Innovation System: The Case of Agricultural Knowledge Sharing—Liliana Mitkova
11. IPR Regime for Agricultural Biotechnology in India—Asha Sinha, Ashwani Kumar, Seweta Srivastava, Rajendra Kumar, Sujit K Yadav, Ravindra Kumar & Vinit P Singh

Part 3: Intellectual Property Issues in Industrial Biotechnology
12. DNA Patenting—Michael Blakeney
13. The Development of Patentability of Genetic Patent in Mainland China and Taiwan—Chien-Te Fan, Jui-Chu Lin & Tzu-Hsun Hung
14. Bioprospecting Microbial Diversity: IPR Issues—Aabheejeet Pansare, Sunil K Dhar & Om Prakash
15. CRISPR/Cas9 system, A Revolutionary Technology for Genome Editing: Applications and IP Disputes—Akanksha Singh & Rakesh Pandey, Birichi K Sarma, Chetan Keswani, Kartikay Bisen,
Sandhya Mishra & Harikesh Bahadur Singh

Section 4: Intellectual Property Issues in Pharmaceutical Biotechnology
16. Healthcare Innovation, Personalization, and the Patent System: Where is the Public Interest? —Graham Dutfield
17. Patentability of Human Embryo Stem Cell: A Comparative Analyse of Case WARF in United States and
Europe—Jiang Li
18. Innovation and Intellectual Property Issues in the “Decade of Vaccines”: a Brazilian Perspective—Adelaide Antunes & Flavia M L Mendes, Akira Homma & Reinaldo M. Martins, Cristina Possas
19. Promoting Access To Health Care Through Biosimilars: Addressing Intellectual Property Rights And Regulatory Barriers—Kanikaram Satyanarayana
20. Changing Paradigm for IPR Protection in Drug Discovery Research: Where India Stands
21. Intellectual Property Rights in Drug Development and Biotechnology
22. Leishmaniasis: Drug Development and IP Issues

Harikesh Bahadur Singh

Harikesh Bahadur Singh is Head of the Department of Mycology and Plant Pathology, Institute of Agricultural Sciences, Banaras Hindu University, India. He has been decorated with several National awards and honors for his key role in popularizing organic farming and translating agriculturally important microorganisms from lab to land. To his credit, he has 20 U.S. patents which he has successfully transferred for commercial production of bio-pesticides to several industrial houses in India.

Alok Jha

Alok Jha is Assistant Director General (International Relations) ICAR, India.

Chetan Keswani

Chetan Keswani is a Post-Doctoral Fellow in the Department of Mycology & Plant Pathology, Institute of Agricultural Sciences, Banaras Hindu University, India. Trained as a Biochemist he has keen interest in Intellectual Issues in Life Sciences. He has also passed several courses from World Intellectual Property Organization, Geneva, Switzerland. He has been a Key Note speaker in several National and International Conferences to discuss various issues in Intellectual Property and Biotechnology.